Sudden Cardiac Death News and Research

RSS

The term sudden cardiac death refers to natural death from cardiac causes, heralded by abrupt loss of consciousness within one hour of the onset of acute symptoms.

Impaired cardiac metabolism linked to increased risk of fatal arrhythmias or sudden cardiac death

Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening arrhythmias (an irregular heart rhythm), and MRI techniques could be used to detect the condition and predict future sudden cardiac death (SCD), according to a small, but rigorous study led by Johns Hopkins Medicine researchers.

11 Jul 2022

Deciphering the structure of nuclear pore complex piece by piece

Whatever you are doing, whether it is driving a car, going for a jog, or even at your laziest, eating chips and watching TV on the couch, there is an entire suite of molecular machinery inside each of your cells hard at work.

10 Jun 2022

New electrical test to screen individuals at risk of sudden cardiac arrest

New research from the Victor Chang Cardiac Research Institute will allow families around the world to discover if they are carrying genetic mutations that cause sudden cardiac arrest – a condition that kills nine out of 10 victims.

9 Jun 2022

Scientists identify core factors that may put Long QT patients at higher risk of sudden cardiac death

Less than 1 percent of the population has been diagnosed with Long QT syndrome – a rare heart condition that can cause chaotic, sometimes fatal, heart rhythms.

27 May 2022

AI predicts if or when a patient could die of cardiac arrest

In a recent study published in the journal Nature Cardiovascular Research, researchers used deep learning (DL) assessment of the scarring in the heart to predict arrhythmia-associated sudden death survival.

24 May 2022

Single-cell RNA sequencing reveals characteristics of myeloid immune cells in coronary plaque

Through single-cell RNA sequencing, a research group has successfully illuminated the characteristics of Myeloid immune cells in coronary plaque, which causes acute coronary syndrome (this term includes conditions such as unstable angina and acute myocardial infarction (heart attack)).

6 May 2022

Researchers uncover a key regulator of pregnancy-associated heart growth

Northwestern Medicine scientists have uncovered a key regulator of pregnancy-associated heart growth, according to a recent study published in the Journal of Clinical Investigation.

18 Apr 2022

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

Heart complications are uncommon, yet treatable for children and young adults after COVID-19 disease or SARS-CoV-2 infection, according to a new scientific statement from the American Heart Association that details what has been learned about how to treat, manage and even prevent cardiovascular complications from the SARS-CoV-2 virus in youth.

12 Apr 2022

ECG can pinpoint hospitalized COVID-19 patients at high risk of mortality

A simple electrocardiogram (ECG) can pinpoint hospitalized COVID-19 patients at high risk of death who might need intensive management. That's the finding of a study presented at EHRA 2022, a scientific congress of the European Society of Cardiology.

4 Apr 2022

Overweight patients more likely to experience recurrent atrial fibrillation after ablation

Overweight patients with atrial fibrillation are more likely to experience a return of the heart rhythm disorder after a corrective procedure than those of normal weight, according to research presented at EHRA 2022, a scientific congress of the European Society of Cardiology.

4 Apr 2022

Consensus document offers recommendations on genetic testing for inherited cardiac diseases

When should patients and family members undergo genetic assessment for a heart condition? Find out in an international consensus document published in EP Europace, a journal of the European Society of Cardiology and presented at EHRA 2022, a scientific congress of the ESC.

4 Apr 2022

Extension study shows mavacamten’s efficacy and safety in treating hypertrophic cardiomyopathy

Use of mavacamten, a novel cardiac myosin inhibitor, to treat people with symptomatic obstructive hypertrophic cardiomyopathy (HCM), a condition that results in excess thickening of the heart muscle, resulted in continued benefits in patient quality of life and outcomes over an extended period of time, according to interim data from the EXPLORER-HCM extension study presented at the American College of Cardiology's 71st Annual Scientific Session.

3 Apr 2022

First practical guide on the use of digital devices for heart rhythm and rate monitoring published

Who should monitor their heart rate and rhythm and which device should they use? Find out in an international consensus document published today in EP Europace, a journal of the European Society of Cardiology (ESC) and presented at EHRA 2022, a scientific congress of the ESC.

3 Apr 2022

Recommendations to prevent, manage interference in patients with implanted cardiac devices

Recommendations on the prevention and management of interference caused by medical procedures in patients with implanted electronic cardiac devices is published today in EP Europace, a journal of the European Society of Cardiology and presented at EHRA 2022, a scientific congress of the ESC.

3 Apr 2022

Experimental drug for hypertrophic cardiomyopathy reduces the need for invasive procedures, trial shows

Findings from a Cleveland Clinic-led clinical trial showed that the use of an experimental drug in severely symptomatic, hypertrophic cardiomyopathy patients significantly reduced the need for invasive procedures.

2 Apr 2022

Clinical algorithm distinguishes between untreatable and treatable form of sudden cardiac arrest

Clinician-scientists in the Smidt Heart Institute at Cedars-Sinai developed a clinical algorithm that, for the first time, distinguishes between treatable sudden cardiac arrest and untreatable forms of the condition.

31 Mar 2022

Study identifies 10 new genetic regions linked with Brugada syndrome

A recent study published in Nature Genetics identified 10 new genetic regions associated with Brugada syndrome, a cardiac arrhythmia disorder associated with sudden death in young adults.

30 Mar 2022

Study: Almost half of over-35s not confident in recognizing cardiac risk during exercise

A new study assessing the knowledge and confidence in recognizing cardiac symptoms has found that almost half of over-35s were not confident in their ability to recognize symptoms of impending cardiac risk – such as a heart attack or sudden cardiac death – while participating in strenuous exercise.

14 Mar 2022

Researchers show a relationship between regionalized myocardial fibrosis and mitral valve prolapse

The larger the sail, the more wind it catches. But as that size increases, so does the stress experienced by each sheet and line connected to the canvas.

28 Feb 2022

The 'Ross procedure' may be a more favorable option for aortic valve replacement in younger adults

The "Ross procedure" may be a more favorable option for aortic valve replacement among patients under 50 years old than more standard mechanical or biological replacements, according to a new study from The Mount Sinai Hospital in New York City.

21 Feb 2022

Sudden Cardiac Death News and Research

Further Reading

Impaired cardiac metabolism linked to increased risk of fatal arrhythmias or sudden cardiac death

Deciphering the structure of nuclear pore complex piece by piece

New electrical test to screen individuals at risk of sudden cardiac arrest

Scientists identify core factors that may put Long QT patients at higher risk of sudden cardiac death

AI predicts if or when a patient could die of cardiac arrest

Single-cell RNA sequencing reveals characteristics of myeloid immune cells in coronary plaque

Researchers uncover a key regulator of pregnancy-associated heart growth

Heart complications uncommon for children and young adults after SARS-CoV-2 infection

ECG can pinpoint hospitalized COVID-19 patients at high risk of mortality

Overweight patients more likely to experience recurrent atrial fibrillation after ablation

Consensus document offers recommendations on genetic testing for inherited cardiac diseases

Extension study shows mavacamten’s efficacy and safety in treating hypertrophic cardiomyopathy

First practical guide on the use of digital devices for heart rhythm and rate monitoring published

Recommendations to prevent, manage interference in patients with implanted cardiac devices

Experimental drug for hypertrophic cardiomyopathy reduces the need for invasive procedures, trial shows

Clinical algorithm distinguishes between untreatable and treatable form of sudden cardiac arrest

Study identifies 10 new genetic regions linked with Brugada syndrome

Study: Almost half of over-35s not confident in recognizing cardiac risk during exercise

Researchers show a relationship between regionalized myocardial fibrosis and mitral valve prolapse

The 'Ross procedure' may be a more favorable option for aortic valve replacement in younger adults

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News